Kazakhstan ramps up purchase of pharmaceuticals to treat COVID-19
NUR-SULTAN. KAZINFORM – Purchase of pharmaceuticals for COVID-19 treatment to form a two-month reserve has been ramped up in Kazakhstan, Kazinform correspondent reports.
According to Yerkhat Iskaliyev, Chairman of the Board of SK-Pharmacy, 50 highly demanded pharmaceuticals worth 24 billion tenge are being purchased. The pharmaceuticals are said to last for two months and allow treating 100 thousand patients in one month in case of the possible second wave of COVID-19.
Iskaliyev also mentioned five new pharmaceuticals added to treat the COVID-19 virus among patients with mild and moderate symptoms. They include anti-inflammatory pharmaceuticals such as Paracetamol, Ibuprofen as well as anticoagulants Rivaroxaban, Apixaban and Dabigatran.
- Uzbekistan registers an all-time high of new coronavirus cases in past day
- Kostanay rgn reports over 200 daily COVID-19 cases
- New virus cases in 1,300s for 2nd day; virus fight dogged by delta variant, vacationers
- Kazakhstan’s 16 areas in ‘red zone’ for COVID-19
- Over 87 thou people under COVID-19 treatment in Kazakhstan
- COVID-19-like pneumonia affects 23 in Kazakhstan in 24 hrs
- Speeches of the President of the Republic of Kazakhstan
- President's Address to the Nation
- Development of the President's Message
- Foreign Mass Media about Kazakhstan
- World and Crisis